Package 43598-465-62

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 43598-465-62
Digits Only 4359846562
Product NDC 43598-465
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (43598-465-62)

Marketing

Marketing Status
Marketed Since 2015-06-19
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "432d4f82-fcf0-c5f5-6da1-d55db90e59b0", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["33397835-15a9-d89f-bd75-8b915f5c4dbf"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (43598-465-62)", "package_ndc": "43598-465-62", "marketing_start_date": "20150619"}], "brand_name": "Azacitidine", "product_id": "43598-465_432d4f82-fcf0-c5f5-6da1-d55db90e59b0", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "43598-465", "generic_name": "Azacitidine", "labeler_name": "Dr. Reddy's Laboratories Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA201537", "marketing_category": "ANDA", "marketing_start_date": "20150619", "listing_expiration_date": "20261231"}